Global Human Milk Oligosaccharides (HMO) Market

Global Human Milk Oligosaccharides (HMO) Market Size, Share, Growth Analysis, By Type(2'-FL & 3-FL, Sialyllactose), By Application(Segmented as, Infant Formula) - Industry Forecast 2024-2031


Report ID: SQMIG30I2309 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 65 | Figures: 75

Global Human Milk Oligosaccharides (HMO) Market Insights

Global Human Milk Oligosaccharides (HMO) Market size was valued at USD 177.91 Million in 2022 and is poised to grow from USD 195.17 Million in 2023 to USD 409.32 Million by 2031, at a CAGR of 9.7% during the forecast period (2024-2031). 

The human milk oligosaccharides (HMO) market is becoming progressively more well-known as a vital element of the wellness and nutrition of infants. HMOs, or complex carbohydrates, are found naturally in human breast milk and are known to offer a variety of health advantages. These bioactive substances support the maturation of the infant's immune system, gastrointestinal health, and cognitive abilities. As our understanding of HMOs grows, there are more and more potential uses for them outside of baby nutrition, as in the fields of medicines, functional foods, and prebiotic supplements.

Growing public knowledge of HMOs' health benefits and the goal of making infant formula more like breast milk are the main factors driving market expansion. The capacity of HMOs to promote immunological and gut health is consistent with the growing trend of looking for natural and comprehensive remedies. The identification and creation of unique HMO arrangements to target distinct health advantages is another area of study attention.

However, challenges include the complexity and cost of HMO production, especially when replicating the diverse array of HMOs found in breast milk. Regulatory considerations and potential intellectual property hurdles also impact market dynamics. As HMO research continues to evolve, the market holds promise not only for infant nutrition but also for addressing various health concerns across the lifecycle. The potential to revolutionize the concept of nutrition and wellbeing underscores the significance of the HMO market in shaping the future of healthcare and functional foods.

US Human Milk Oligosaccharides (HMO) Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Human Milk Oligosaccharides (HMO) Market size was valued at USD 177.91 Million in 2022 and is poised to grow from USD 195.17 Million in 2023 to USD 409.32 Million by 2031, at a CAGR of 9.7% during the forecast period (2024-2031). 

The human milk oligosaccharides (HMO) market is very competitive, with both well-established manufacturers and creative entrants vying for market share as demand for HMO-fortified products rises. Prominent competitors include DuPont Nutrition & Biosciences, Nestlé S.A., Glycosyn LLC, Jennewein Biotechnologie GmbH, and Elicityl owing to their experience producing HMOs, their capacity for extensive research, and their established relationships in the infant nutrition and functional foods industries. 'DuPont Nutrition & Biosciences', 'Nestlé S.A.', 'Glycosyn LLC', 'Jennewein Biotechnologie GmbH', 'Elicityl', 'Inbiose', 'ZuChem Inc.', 'Glycom A/S', 'TMO Renewables Ltd.', 'Abbott Laboratories', 'Evolve Biosystems', 'Quantum Biotechnologies Inc.', 'Novalac', 'ZuChem Inc.', 'Clasado Biosciences', 'Metabiotics Corporation', 'Medolac Laboratories', 'HMO Research GmbH', 'Jennewein Biotechnologie', 'Holton BioSystems'

The growing awareness of the advantages of human milk oligosaccharides (HMOs) for health is an important driver . Demand for HMO-fortified goods has increased as a result of the role that HMOs play in promoting the immune system, cognitive development, and gut health of infants as well as possible benefits for adults.

Expanding Applications Beyond Infant Nutrition: Although HMOs have historically been linked to baby feeding and are found naturally in breast milk, there is a rising movement to investigate their potential in other contexts. HMOs are being researched for use in functional foods, dietary supplements, and even medications to treat a range of health issues in people of different ages.

The human milk oligosaccharides (HMO) market showed notable regional variations, with North America having the largest market share. North America's advanced baby feeding business, robust research capacity, and increasing consumer demand for HMO-fortified goods are the reasons for its dominance. The notable use of HMOs in infant formula and related products can be attributed to the region's focus on ensuring optimal infant health and development.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Human Milk Oligosaccharides (HMO) Market

Product ID: SQMIG30I2309

$5,300
BUY NOW GET FREE SAMPLE